Follow
Suzanne Farid
Suzanne Farid
Professor in Biochemical Engineering, UCL
Verified email at ucl.ac.uk
Title
Cited by
Cited by
Year
Process economics of industrial monoclonal antibody manufacture
SS Farid
Journal of Chromatography B 848 (1), 8-18, 2007
4422007
Fed‐batch and perfusion culture processes: Economic, environmental, and operational feasibility under uncertainty
J Pollock, SV Ho, SS Farid
Biotechnology and Bioengineering, 2012
3052012
Allogeneic cell therapy bioprocess economics and optimization: Single‐use cell expansion technologies
AS Simaria, S Hassan, H Varadaraju, J Rowley, K Warren, P Vanek, ...
Biotechnology and bioengineering 111 (1), 69-83, 2014
2122014
Integrated continuous bioprocessing: economic, operational, and environmental feasibility for clinical and commercial antibody manufacture
J Pollock, J Coffman, SV Ho, SS Farid
Biotechnology progress 33 (4), 854-866, 2017
1522017
Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture
J Pollock, G Bolton, J Coffman, SV Ho, DG Bracewell, SS Farid
Journal of Chromatography A 1284, 17-27, 2013
1512013
Shear stress analysis of mammalian cell suspensions for prediction of industrial centrifugation and its verification
N Hutchinson, N Bingham, N Murrell, S Farid, M Hoare
Biotechnology and bioengineering 95 (3), 483-491, 2006
1422006
Decision‐Support Tool for Assessing Biomanufacturing Strategies under Uncertainty: Stainless Steel versus Disposable Equipment for Clinical Trial Material Preparation
SS Farid, J Washbrook, NJ Titchener‐Hooker
Biotechnology progress 21 (2), 486-497, 2005
1402005
Human pluripotent stem cell‐derived products: Advances towards robust, scalable and cost‐effective manufacturing strategies
MJ Jenkins, SS Farid
Biotechnology journal 10 (1), 83-95, 2015
1092015
A computer‐aided approach to compare the production economics of fed‐batch and perfusion culture under uncertainty
AC Lim, J Washbrook, NJ Titchener‐Hooker, SS Farid
Biotechnology and bioengineering 93 (4), 687-697, 2006
872006
Established bioprocesses for producing antibodies as a basis for future planning
SS Farid
Cell Culture Engineering, 1-42, 2006
842006
Industry 4.0: a vision for personalized medicine supply chains?
J Branke, SS Farid, N Shah
Cell and Gene Therapy Insights 2 (2), 263-270, 2016
812016
Allogeneic cell therapy bioprocess economics and optimization: downstream processing decisions
S Hassan, AS Simaria, H Varadaraju, S Gupta, K Warren, SS Farid
Regenerative medicine 10 (5), 591-609, 2015
802015
A roadmap for cost-of-goods planning to guide economic production of cell therapy products
YY Lipsitz, WD Milligan, I Fitzpatrick, E Stalmeijer, SS Farid, KY Tan, ...
Cytotherapy 19 (12), 1383-1391, 2017
772017
Impact of allogeneic stem cell manufacturing decisions on cost of goods, process robustness and reimbursement
TDP Chilima, F Moncaubeig, SS Farid
Biochemical engineering journal 137, 132-151, 2018
712018
Autologous CAR T-cell therapies supply chain: challenges and opportunities?
MM Papathanasiou, C Stamatis, M Lakelin, S Farid, N Titchener-Hooker, ...
Cancer gene therapy 27 (10), 799-809, 2020
682020
Modelling biopharmaceutical manufacture: Design and implementation of SimBiopharma
SS Farid, J Washbrook, NJ Titchener-Hooker
Computers & chemical engineering 31 (9), 1141-1158, 2007
682007
Technologies for large-scale umbilical cord-derived MSC expansion: Experimental performance and cost of goods analysis
A Mizukami, TDP Chilima, MD Orellana, MA Neto, DT Covas, SS Farid, ...
Biochemical Engineering Journal, 2018
612018
Modelling of the biopharmaceutical drug development pathway and portfolio management
A Rajapakse, NJ Titchener-Hooker, SS Farid
Computers & chemical engineering 29 (6), 1357-1368, 2005
602005
Application of a Decision‐Support Tool to Assess Pooling Strategies in Perfusion Culture Processes under Uncertainty
AC Lim, Y Zhou, J Washbrook, A Sinclair, B Fish, R Francis, ...
Biotechnology progress 21 (4), 1231-1242, 2005
572005
Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&D
SS Farid, M Baron, C Stamatis, W Nie, J Coffman
Mabs 12 (1), 1754999, 2020
552020
The system can't perform the operation now. Try again later.
Articles 1–20